ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
ARS Pharmaceuticals, a biopharmaceutical company focused on treatments for severe allergic reactions, announced that its President and CEO, Donn Casale, will participate in the Wells Fargo Healthcare Conference and Cantor Global Healthcare Conference in September 2026. The company is commercializing neffy® (epinephrine nasal spray) for emergency tr…